MTBP inhibits the Erk1/2-Elk-1 signaling in hepatocellular carcinoma.

Ranjan, Atul; Iyer, Swathi V; Ward, Christopher; Link, Tim; Diaz, Francisco J; Dhar, Animesh; Tawfik, Ossama W; Weinman, Steven A; Azuma, Yoshiaki; Izumi, Tadahide; Iwakuma, Tomoo

Ranjan, Atul; Iyer, Swathi V; Ward, Christopher; Link, Tim; Diaz, Francisco J; Dhar, Animesh; Tawfik, Ossama W; Weinman, Steven A; Azuma, Yoshiaki; Izumi, Tadahide; Iwakuma, Tomoo.

Afiliação

Ranjan A; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA.
Iyer SV; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA.
Ward C; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA.
Link T; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA.
Diaz FJ; Department of Biostatistics, University of Kansas Medical Center, Kansas City, KS, USA.
Dhar A; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA.
Tawfik OW; Department of Pathology, University of Kansas Medical Center, Kansas City, KS, USA.
Weinman SA; Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA.
Azuma Y; Department of Molecular Bioscience, University of Kansas, Lawrence, KS, USA.
Izumi T; Department of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, KY, USA.
Iwakuma T; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA.

Oncotarget ; 9(30): 21429-21443, 2018 Apr 20.

Article em En | MEDLINE | ID: mdl-29765550

Palavras-chave

Elk-1; Erk1/2; MDM2; MTBP; metastasis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Oncotarget Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google